World CDx 2026 has ended. This guide stays up as the record of who was there. Next: World CDx 2027, Aug 30 – Sep 2, 2027 in Boston

Immunome at World CDx 2026

Oct 5–8, 2026 Boston, MA ~900 attendees Website

Immunome takes part in 2 sessions at World CDx 2026 in Boston. Its program centers on biomarker strategy for biotech companies developing cancer drugs. With Agenus, Beacon Scientific Consulting and Incendia Therapeutics, it looks at precision oncology strategies that deliver both clinical and commercial value.

OrganizationWorld CDx 2026 Attendance
Immunome
Bothell, WA
immunome.com
Biotech
Clinical-stage oncology company developing targeted cancer therapies, including antibody-drug conjugates.
Chair
Wed Oct 7
11:18am
Stream chair
with Daiichi Sankyo, Compass Therapeutics
Panel
Wed Oct 7
3:10pm
Navigating Biomarker Complexity as a Biotech to Build Smarter Precision Oncology Strategies that Maximize Clinical & Commercial Impact
with Agenus, Beacon Scientific Consulting, Incendia Therapeutics +1 more
Biomarker discovery & translationDrug–diagnostic commercialization & access

Explore the full World CDx 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full World CDx 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Immunome

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by World CDx or its organizers. Submit a correction